Prime Medicine, Inc. (PRME)

Import this data to Google Sheets with:

=jivedata("PRME","financials")

Full statements spill as a table. For one cell: =jivedata("PRME","Revenue") or =jivedata("PRME","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

Prime Medicine, Inc.

PRME • CIK 0001894562

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Operating Income (Loss)	$-204,792	$-202,467	$-208,350	$-196,520
Net Income (Loss) Available to Common Stockholders, Basic	$-198,133	$-195,882	$-201,142	$-187,892
Weighted Average Number of Shares Outstanding, Diluted	90,969,327	118,600,381	148,758,527	197,480,092
Revenue from Contract with Customer, Excluding Assessed Tax	—	$2,983	$4,632	$4,632
Research and Development Expense	$147,905	$155,289	$160,636	$146,201
General and Administrative Expense	$43,387	$50,161	$52,346	$54,392
Operating Expenses	$204,792	$205,450	$212,982	$200,593
Investment Income, Interest	—	$3,522	$4,149	$4,033
Accretion (Amortization) of Discounts and Premiums, Investments	$3,408	$3,507	$2,479	$2,403
Other Nonoperating Income (Expense)	$8,762	$41	$148	$199
Nonoperating Income (Expense)	$6,380	$6,585	$7,208	$8,628
OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax	$369	$16	$81	$1
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	$-197,764	$-195,866	$-201,061	$-187,891

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Property, Plant and Equipment, Net	$22,659	$24,404	$20,572	$17,077
Operating Lease, Right-of-Use Asset	$13,941	$47,156	$126,177	$120,468
Restricted Cash, Noncurrent	$13,496	$14,062	$13,691	$13,691
Other Assets, Noncurrent	$779	$0	$1,000	$1,000
Assets	$193,851	$297,508	$342,733	$249,040
Contract with Customer, Liability, Noncurrent	—	$63,218	$58,127	$56,033
Operating Lease, Liability, Noncurrent	$4,357	$37,180	$108,290	$103,506
Liabilities	$60,780	$144,359	$221,865	$209,231
Cash and Cash Equivalents, at Carrying Value	$41,574	$182,476	$63,032	$47,451
Prepaid Expense, Current	$19,057	$6,777	$2,939	$1,357
Other Assets, Current	$2,254	$14,667	$674	$376
Assets, Current	$142,976	$211,886	$181,293	$96,804
Accounts Payable, Current	$19,537	$11,351	$8,887	$5,808
Accrued Liabilities, Current	$14,110	$15,904	$12,600	$8,978
Contract with Customer, Liability, Current	—	$7,092	$7,824	$7,934
Operating Lease, Liability, Current	$9,276	$3,614	$8,137	$8,972
Liabilities, Current	$56,423	$37,961	$37,448	$31,692
Common Stock, Value, Issued	$2	$2	$2	$2
Additional Paid in Capital	$624,414	$840,358	$1,009,138	$1,019,401
Accumulated Other Comprehensive Income (Loss), Net of Tax	$-15	$1	$82	$-9
Retained Earnings (Accumulated Deficit)	$-491,330	$-687,212	$-888,354	$-979,585
Stockholders' Equity Attributable to Parent	$133,071	$153,149	$120,868	$39,809
Common Stock, Shares Authorized	775,000,000	775,000,000	775,000,000	775,000,000
Common Stock, Shares, Issued	97,377,121	131,160,842	180,514,014	180,737,548

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss) Attributable to Parent	$-198,133	$-195,882	$-201,142	$-187,892
Net Cash Provided by (Used in) Operating Activities	$-165,412	$-122,865	$-162,564	$-156,051
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-146,046	$141,468	$-119,815	$-6,353
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$55,070	$196,538	$76,723	$48,581
Share-based Payment Arrangement, Noncash Expense	$13,910	$26,068	$29,268	$26,771
Proceeds from Maturities, Prepayments and Calls of Short-term Investments	$132,556	$204,200	$95,781	$175,484
Operating Lease, Right-of-Use Asset, Amortization Expense	$12,788	$12,355	$9,698	$10,646
Proceeds from Sale of Other Investments	—	—	$5,400	$5,400
Depreciation, Depletion and Amortization	$4,653	$6,128	$7,321	$7,398
Payments to Acquire Short-term Investments	$104,951	$129,449	$205,413	$176,458
Increase (Decrease) in Equity Securities, FV-NI	$-2,382	$-484	$432	$1,993
Payments to Acquire Property, Plant, and Equipment	$8,724	$7,294	$4,531	$797
Net Cash Provided by (Used in) Investing Activities	$18,711	$68,457	$-108,763	$3,629
Increase (Decrease) in Prepaid Expense and Other Assets	$9,455	$15,859	$-4,545	$-5,773
Increase (Decrease) in Accounts Payable	$9,140	$-5,257	$996	$-509
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities	$1,758	$1,843	$-1,160	$-3,092
Proceeds from Stock Options Exercised	$655	$103	$781	$1,197
Increase (Decrease) in Contract with Customer, Liability	—	$70,310	$-4,359	$-3,910
Proceeds from Issuance of Common Stock	—	$38,081	$0	$0
IncreaseDecreaseInOperatingLeaseLiability	$-12,296	$-6,461	$-5,362	$-7,258
Proceeds from Issuance of Warrants	—	$18,800	$0	$0
Net Cash Provided by (Used in) Financing Activities	$655	$195,876	$151,512	$146,069
Restricted Cash	$13,496	$14,062	$13,691	$13,320
Cash and Cash Equivalents, at Carrying Value	$41,574	$182,476	$63,032	$35,261
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	$3,265	$44,935	$83,757	$0
Capital Expenditures Incurred but Not yet Paid	$575	$1,154	$114	$-34

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("PRME","financials")

Full statements spill as a table. For one cell: =jivedata("PRME","Revenue") or =jivedata("PRME","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.